345 related articles for article (PubMed ID: 32389264)
41. MRI features of pediatric atypical teratoid rhabdoid tumors and medulloblastomas of the posterior fossa.
Wu HW; Wu CH; Lin SC; Wu CC; Chen HH; Chen YW; Lee YY; Chang FC
Cancer Med; 2023 May; 12(9):10449-10461. PubMed ID: 36916326
[TBL] [Abstract][Full Text] [Related]
42. Central nervous system tumors in patients under three years of age: treatment results of a single institute.
Varan A; Akalan N; Söylemezoğlu F; Zorlu F; Yalçin B; Akyüz C; Kutluk T; Büyükpamukçu M
Pediatr Neurosurg; 2006; 42(2):89-94. PubMed ID: 16465077
[TBL] [Abstract][Full Text] [Related]
43. A role for fluorescence in situ hybridization detection of chromosome 22q dosage in distinguishing atypical teratoid/rhabdoid tumors from medulloblastoma/central primitive neuroectodermal tumors.
Bruch LA; Hill DA; Cai DX; Levy BK; Dehner LP; Perry A
Hum Pathol; 2001 Feb; 32(2):156-62. PubMed ID: 11230702
[TBL] [Abstract][Full Text] [Related]
44. A Case Presentation: Rare Occurrence of an Adolescent Male Presenting With an ATRT and Simultaneous Low-grade Glioneuronal Tumor.
Cascio M; Rivera-Zengotita M; Fort J
J Pediatr Hematol Oncol; 2017 Nov; 39(8):e456-e459. PubMed ID: 28731919
[TBL] [Abstract][Full Text] [Related]
45. Successful peripheral blood stem cell harvesting for two pediatric cases of atypical teratoid/rhabdoid tumor with low bodyweight.
Mitani K; Ogata H; Takachi T; Fukui W; Kawaguchi K; Ogura T; Horikoshi Y; Kawasaki T; Watanabe K
Pediatr Blood Cancer; 2024 Mar; 71(3):e30833. PubMed ID: 38177070
[No Abstract] [Full Text] [Related]
46. Advances in the molecular classification of pediatric brain tumors: a guide to the galaxy.
Cacciotti C; Fleming A; Ramaswamy V
J Pathol; 2020 Jul; 251(3):249-261. PubMed ID: 32391583
[TBL] [Abstract][Full Text] [Related]
47. C19MC amplification and expression of Lin28A and Olig2 in the classification of embryonal tumors of the central nervous system: A 14-year retrospective study from a tertiary care center.
Nambirajan A; Gurung N; Suri V; Sarkar C; Kumar A; Singh M; Sharma MC
Childs Nerv Syst; 2021 Apr; 37(4):1067-1075. PubMed ID: 33236184
[TBL] [Abstract][Full Text] [Related]
48. Advances in Diagnostic Immunohistochemistry for Primary Tumors of the Central Nervous System.
Meredith DM
Adv Anat Pathol; 2020 May; 27(3):206-219. PubMed ID: 30720470
[TBL] [Abstract][Full Text] [Related]
49. [Atypical teratoid/rhabdoid tumors of childhood].
Mitrofanova AM; Konovalov DM; Kisliakov AN; Roshchin VIu; Abramov DS
Arkh Patol; 2013; 75(5):36-42. PubMed ID: 24341231
[TBL] [Abstract][Full Text] [Related]
50. [Atypical teratoid/rhabdoid tumor (AT/RT)].
Biernat W
Pol J Pathol; 2001; 52(4 Suppl):139-40. PubMed ID: 11987601
[No Abstract] [Full Text] [Related]
51. Atypical teratoid rhabdoid tumor in childhood, 15 cases of a single institute experience.
Al-Hussaini M; Dissi N; Al-Jumaily U; Swaidan M
Turk Patoloji Derg; 2014; 30(1):43-54. PubMed ID: 24448710
[TBL] [Abstract][Full Text] [Related]
52. Atypical teratoid/rhabdoid tumor in the sella turcica of an elderly female with a distinct vascular pattern and genetic alterations.
Nobusawa S; Nakata S; Hirato J; Kawashima T; Sato K; Fujimaki H; Okura N; Ikota H; Yokoo H
Virchows Arch; 2016 Dec; 469(6):711-715. PubMed ID: 27595781
[No Abstract] [Full Text] [Related]
53. Atypical teratoid/rhabdoid tumors of the central nervous system: clinical, radiographic and pathologic features.
Bambakidis NC; Robinson S; Cohen M; Cohen AR
Pediatr Neurosurg; 2002 Aug; 37(2):64-70. PubMed ID: 12145514
[TBL] [Abstract][Full Text] [Related]
54. Molecular pathological insights reveal a high number of unfavorable risk patients among children treated for medulloblastoma and CNS-PNET in Oslo 2005-2017.
Niehusmann P; Stensvold E; Leske H; Pietsch T; Goschzik T; Gielen GH; Due-Tønnessen B; Frič R; Nilssen Y; Brandal P
Pediatr Blood Cancer; 2022 Sep; 69(9):e29736. PubMed ID: 35570402
[TBL] [Abstract][Full Text] [Related]
55. Atypical teratoid/rhabdoid tumors of the central nervous system.
Reddy AT
J Neurooncol; 2005 Dec; 75(3):309-13. PubMed ID: 16195799
[TBL] [Abstract][Full Text] [Related]
56. PHOX2B is a reliable immunomarker in distinguishing peripheral neuroblastic tumours from CNS embryonal tumours.
Alexandrescu S; Paulson V; Dubuc A; Ligon A; Lidov HG
Histopathology; 2018 Sep; 73(3):483-491. PubMed ID: 29758594
[TBL] [Abstract][Full Text] [Related]
57. Population-based analysis of CNS tumor diagnoses, treatment, and survival in congenital and infant age groups.
Hart M; Anderson-Mellies A; Beltrami A; Gilani A; Green AL
J Neurooncol; 2022 Apr; 157(2):333-344. PubMed ID: 35175546
[TBL] [Abstract][Full Text] [Related]
58. Molecular pathology of tumors of the central nervous system.
Kristensen BW; Priesterbach-Ackley LP; Petersen JK; Wesseling P
Ann Oncol; 2019 Aug; 30(8):1265-1278. PubMed ID: 31124566
[TBL] [Abstract][Full Text] [Related]
59. The Role of Immunotherapy in the Treatment of Rare Central Nervous System Tumors.
Rodriguez A; Kamiya-Matsuoka C; Majd NK
Curr Oncol; 2023 May; 30(6):5279-5298. PubMed ID: 37366884
[TBL] [Abstract][Full Text] [Related]
60. Atypical teratoid/rhabdoid tumors.
Dang T; Vassilyadi M; Michaud J; Jimenez C; Ventureyra EC
Childs Nerv Syst; 2003 Apr; 19(4):244-8. PubMed ID: 12682757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
